The global market for Self-Expanding Stents was estimated at US$3.8 Billion in 2024 and is projected to reach US$4.5 Billion by 2030, growing at a CAGR of 3.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Self-Expanding Stents market.
Global Self-Expanding Stents Market - Key Trends & Drivers Summarized
Why Is The Demand For Self-Expanding Stents Growing In Cardiovascular And Peripheral Procedures?
Self-expanding stents have become a cornerstone in interventional cardiology and vascular procedures due to their ability to improve blood flow in patients with narrowed or blocked arteries. Unlike balloon-expandable stents, which require external pressure to open, self-expanding stents expand automatically upon deployment, offering greater flexibility and adaptability to vessel movement. The rising prevalence of cardiovascular diseases (CVDs), including coronary artery disease (CAD) and peripheral artery disease (PAD), is fueling the need for advanced stent technologies. Additionally, the increasing number of minimally invasive procedures is driving demand for self-expanding stents, as they reduce recovery time, lower complication risks, and improve long-term patient outcomes.What Technological Innovations Are Enhancing The Effectiveness Of Self-Expanding Stents?
Advancements in biomaterials and drug-eluting coatings are significantly improving the performance and safety of self-expanding stents. Nitinol (nickel-titanium alloy) stents are becoming the preferred choice due to their superelasticity and resistance to deformation. Drug-eluting stents (DES), which release antiproliferative drugs, are reducing the risk of restenosis (re-narrowing of arteries), ensuring long-term patency. Additionally, bioresorbable stents, which gradually dissolve in the body after healing the artery, are emerging as a promising alternative to permanent implants. Robotic-assisted stent placement and AI-powered imaging are enhancing precision in stent deployment, improving clinical success rates.Which Healthcare Sectors Are Driving The Demand For Self-Expanding Stents?
Hospitals and cardiac catheterization labs are the primary end-users of self-expanding stents, as they are widely used in angioplasty procedures. Ambulatory surgical centers (ASCs) are also witnessing increased adoption of self-expanding stents due to the shift toward outpatient cardiovascular interventions. The geriatric population, which is at higher risk for vascular diseases, is contributing to the growing demand for stent-based treatments. Additionally, advancements in reimbursement policies and healthcare infrastructure in emerging markets are making self-expanding stent procedures more accessible.What Factors Are Fueling The Growth Of The Self-Expanding Stents Market?
The growth in the self-expanding stents market is driven by the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and continuous innovation in stent materials and drug coatings. Regulatory approvals for next-generation stents and expanded healthcare access in developing regions are further boosting market expansion. Additionally, growing awareness of preventive cardiology and advancements in imaging technologies are enhancing patient screening and early intervention. As the demand for safer and more effective vascular treatments continues to rise, the self-expanding stents market is poised for sustained growth.Scope of Study:
The report analyzes the Self-Expanding Stents market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Product Type (Carotid Self-Expanding Stents, Gastrointestinal Self-Expanding Stents, Endovascular Self-Expandable Stents, Others); Application (Fem-Pop Artery, Iliac Artery, Carotid Artery, Biliary, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Others)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Carotid Self-Expanding Stents segment, which is expected to reach US$2.1 Billion by 2030 with a CAGR of a 2.9%. The Gastrointestinal Self-Expanding Stents segment is also set to grow at 2.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $989.1 Million in 2024, and China, forecasted to grow at an impressive 3.0% CAGR to reach $728.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Self-Expanding Stents Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Self-Expanding Stents Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Self-Expanding Stents Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott Laboratories, Alvimedica, amg International GmbH, Andramed GmbH, Balton Sp. z o.o. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 34 companies featured in this Self-Expanding Stents market report include:
- Abbott Laboratories
- Alvimedica
- amg International GmbH
- Andramed GmbH
- Balton Sp. z o.o.
- Becton, Dickinson and Company (BD)
- Biosensors International Group, Ltd.
- Biotronik
- Boston Scientific Corporation
- Cook Medical
- Cordis
- Elixir Medical Corporation
- Endologix LLC
- Eucatech AG
- Hexacath
- InspireMD
- Jotec GmbH
- Lifetech Scientific Corporation
- Medinol Ltd.
- Medtronic
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Optimed Medizinische Instrumente GmbH
- Rontis Corporation
- Sahajanand Medical Technologies
- Stryker Corporation
- Terumo Corporation
- Translumina GmbH
- Vesalio
- W. L. Gore & Associates
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Alvimedica
- amg International GmbH
- Andramed GmbH
- Balton Sp. z o.o.
- Becton, Dickinson and Company (BD)
- Biosensors International Group, Ltd.
- Biotronik
- Boston Scientific Corporation
- Cook Medical
- Cordis
- Elixir Medical Corporation
- Endologix LLC
- Eucatech AG
- Hexacath
- InspireMD
- Jotec GmbH
- Lifetech Scientific Corporation
- Medinol Ltd.
- Medtronic
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Optimed Medizinische Instrumente GmbH
- Rontis Corporation
- Sahajanand Medical Technologies
- Stryker Corporation
- Terumo Corporation
- Translumina GmbH
- Vesalio
- W. L. Gore & Associates
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 64 |
| Published | June 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 3.8 Billion |
| Forecasted Market Value ( USD | $ 4.5 Billion |
| Compound Annual Growth Rate | 3.0% |
| Regions Covered | Global |
